|
|
 | | | |
- close
- close
- close
- close
Cardiome Pharma (CRME) |
Benzinga
Apr 25
Comment
Cardiome Pharma Corp. (NASDAQ: CRME) today announced that it has taken on responsibility for worldwide sales,
marketing, and promotion of BRINAVESS™ (vernakalant IV) pursuant to a
Transition Agreement signed with Merck, known as MSD outside the...
Benzinga
Mar 27
Comment
Cardiome Pharma (NASDAQ: CRME)
oday announces changes to the company's senior management
team. William Hunter, M.D., previously interim Chief Executive Officer
and Director, has been appointed full time President and Chief
Executive...
StreetInsider.com
Mar 15
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cardiome+Pharma+Corp.+%28CRME%29+Posts+Surprise+EPS+of+13c/8187562.html for the full story.
FierceBiotech
Dec 11
Comment
Merck ($MRK) has agreed to write off $30 million of the $50 million its one-time partner Cardiome Pharma owed the pharma giant. Cardiome borrowed the money under a credit facility that Merck set up when they partnered on vernakalant, which had...
Benzinga
Dec 11
Comment
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
StreetInsider.com
Dec 11
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Cardiome+%28CRME%29+Enters+Debt+Settlement+w+Merck+%28MRK%29%3B+Will+Pay+%2420M/7938346.html for the full story.
StreetInsider.com
Nov 13
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Cardiome+Pharma+Corp.+%28CRME%29+Misses+Q3+EPS+by+11c/7872658.html for the full story.
FierceBiotech
Sep 26
Comment
Merck ($MRK) wants to completely sever ties with Cardiome Pharma's ($CRME) treatment vernakalant, as the major drugmaker has decided to return global marketing and development rights to both oral and now IV forms of the atrial fibrillation med,...
StreetInsider.com
Sep 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Cardiome+Pharma+%28CRME%29+Appoints+New+CFO/7742191.html for the full story.
Benzinga
Aug 8
Comment
Cardiome Pharma (NASDAQ: CRME) reported Tuesday financial results for the second quarter ended June 30, 2012. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
